● TIER 1 — FDA-approved / recognizedGRADE AGLP-1 / incretins & amylin
Pramlintide
Amylin analog. Research verification: Partial. 0 human study record(s) in the FitClinicMD studies database.
GOALS · Weight loss
FDA status
Approved: Symlin.
Compounding (503A/503B)
Approved.
DEA
Not controlled.
WADA (sport)
Not listed on 2026 Prohibited List (no matching section found)
Mechanism
Amylin agonist.
Human evidence
No qualifying human studies are catalogued for Pramlintide in our database. It is listed here for transparency and reference only.
Reference only. This page summarizes publicly available regulatory and research information about Pramlintide. It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.